PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Program of Infectious Diseases, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.\', \'Key Laboratory of Tropical Disease Control, Ministry of Education, Sun Yat-sen University, Guangzhou, China.\', \'Department of Immunology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.\', \'Department of Infectious Diseases, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.\', \'Biosafety Laboratory, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2021.580989
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34177879
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Antibody Responses and the Effects of Clinical Drugs in COVID-19 Patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all